The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)Mervyn Singer, Derek C. Angus, Clifford S. Deutschman et al.|JAMA|2016Cited by 28.1k
A minimal common outcome measure set for COVID-19 clinical researchJohn C. Marshall, Halima Salisu-Kabara, Nadine E. Foster et al.|The Lancet Infectious Diseases|2020Cited by 1.8k
Effect of therapeutic drug monitoring-based dose optimization of piperacillin/tazobactam on sepsis-related organ dysfunction in patients with sepsis: a randomized controlled trialStefan Hagel, Hicham Chkirni, Friedhelm Bach et al.|Intensive Care Medicine|2022Cited by 171
Intravascular volume therapy in adultsGernot Marx, Michaela Eikermann, Achim W. Schindler et al.|European Journal of Anaesthesiology|2016Cited by 125
Safety and tolerability of non-neutralizing adrenomedullin antibody adrecizumab (HAM8101) in septic shock patients: the AdrenOSS-2 phase 2a biomarker-guided trialPierre‐François Laterre, Anne-Aurore Duchambon, Peter Pickkers et al.|Intensive Care Medicine|2021Cited by 92